Salus Therapeutics


Public lists: Pharma Startups (6570)

Salus Therapeutics develops oligonucleotide pharmaceuticals intended to block or regulate the production of disease-related proteins at the genetic level.

Salus Therapeutics develops oligonucleotide pharmaceuticals intended to block or regulate the production of disease-related proteins at the genetic level.

Company (Acquired)

All investors data 5 Investors

Phone:

Fax:



Salt Lake City,
Utah, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Salus Therapeutics $4.3M Aug 19, 2003
AVEO Oncology $131.2M Mar 12, 2010
Message Pharmaceuticals $12.5M Oct 1, 2001
See all 15 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Salus Therapeutics Jobs

jobs by Indeed job search

Investors

Investor Investor Type Location Participating Rounds
See all 5 investors

Board Members

Name Firm
Login to see detailsvSpring Capital
Login to see detailsNovus Therapeutics
Login to see detailsPelion Venture Partners

Competitors

Company Status Description Investors
See all 15 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)